Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1554, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose atorvastatin effective in comorbid CHD, CKD

By  

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

High-dose atorvastatin economically IDEAL in CHD

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 526, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

High-dose atorvastatin economically IDEAL in CHD

By  

Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

More support for high-dose atorvastatin in coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2365-2368

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin best value for money for secondary CHD prevention

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 408-409, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite